See also this year's filing and all EDGAR filings for this company.
PDF Report 0001399529_2019_Dicerna_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001399529')"} |
Graph
Absolute values for 0001399529, Dicerna Pharmaceuticals Inc
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 405,514,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 2,718,000 |
3 | remainder_Assets | 809,000 |
4 | LiabilitiesCurrent | 94,055,000 |
5 | LiabilitiesNoncurrent | 114,293,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 21,685,000 |
9 | ResearchAndDevelopmentExpense | 45,711,000 |
10 | remainder_Expenses | 29,132,000 |
11 | remainder_Revenues | 6,176,000 |
12 | remainder_NetIncome | 1,499,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 409,041,000 |
1 | Liabilities | 208,348,000 |
2 | Expenses | 96,528,000 |
3 | Revenues | 6,176,000 |
4 | StockholdersEquity | 200,693,000 |
5 | NetIncome | -88,853,000 |
6 | ComprehensiveNetIncome | -88,853,000 |
7 | BaseVar | 360,796,000 |
8 | EconomicCapitalRatio | 0.830 |